NO913295L - Kodeinsalt av en substituert karboksylsyre, fremgangsmaatefor fremstilling derav og anvendelse derav. - Google Patents

Kodeinsalt av en substituert karboksylsyre, fremgangsmaatefor fremstilling derav og anvendelse derav.

Info

Publication number
NO913295L
NO913295L NO91913295A NO913295A NO913295L NO 913295 L NO913295 L NO 913295L NO 91913295 A NO91913295 A NO 91913295A NO 913295 A NO913295 A NO 913295A NO 913295 L NO913295 L NO 913295L
Authority
NO
Norway
Prior art keywords
salt
preparation
codeal
procedure
carboxylic acid
Prior art date
Application number
NO91913295A
Other languages
English (en)
Other versions
NO179175B (no
NO179175C (no
NO913295D0 (no
Inventor
Walter Riess
Alfred Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO913295D0 publication Critical patent/NO913295D0/no
Publication of NO913295L publication Critical patent/NO913295L/no
Publication of NO179175B publication Critical patent/NO179175B/no
Publication of NO179175C publication Critical patent/NO179175C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO913295A 1990-08-23 1991-08-22 Fremgangsmåte for fremstilling av kodeinsaltet av en substituert karboksylsyre NO179175C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH273590 1990-08-23

Publications (4)

Publication Number Publication Date
NO913295D0 NO913295D0 (no) 1991-08-22
NO913295L true NO913295L (no) 1992-02-24
NO179175B NO179175B (no) 1996-05-13
NO179175C NO179175C (no) 1996-08-21

Family

ID=4240432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913295A NO179175C (no) 1990-08-23 1991-08-22 Fremgangsmåte for fremstilling av kodeinsaltet av en substituert karboksylsyre

Country Status (20)

Country Link
US (1) US5190947A (no)
EP (1) EP0472501B1 (no)
JP (1) JPH04257587A (no)
KR (1) KR920004391A (no)
AT (1) ATE137753T1 (no)
AU (1) AU652951B2 (no)
CA (1) CA2049649A1 (no)
DE (1) DE59107784D1 (no)
DK (1) DK0472501T3 (no)
ES (1) ES2086515T3 (no)
FI (1) FI96421C (no)
GR (1) GR3019872T3 (no)
HU (1) HU209308B (no)
IE (1) IE72479B1 (no)
IL (1) IL99213A (no)
NO (1) NO179175C (no)
NZ (1) NZ239495A (no)
PT (1) PT98731B (no)
TW (1) TW225536B (no)
ZA (1) ZA916642B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072462T3 (es) * 1991-02-07 1995-07-16 Heumann Pharma Gmbh & Co Nuevas sales del acido 2-(2,6-dicloroanilino)fenilacetico, procedimiento para su elaboracion y uso de las mismas en preparados farmaceuticos de uso topico.
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
CA2304722C (en) * 1997-09-25 2005-11-22 Lts Lohmann Therapie-Systeme Ag Acidic addition salts of morphine alkaloids and the application thereof
BR0210179A (pt) * 2001-06-05 2004-04-27 Control Delivery Sys Inc Compostos analgésicos de liberação sustentada
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2491572C (en) * 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
DK1765292T3 (en) 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
US20090291121A1 (en) * 2008-05-23 2009-11-26 Symrise, Inc. Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
PT2405748T (pt) 2009-03-12 2018-11-23 Cumberland Pharmaceuticals Inc Administração de ibuprofeno intravenoso
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2013112456A1 (en) 2012-01-24 2013-08-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Controlled release formulations for the induction and proliferation of blood cells
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA537946A (en) * 1957-03-12 J. Lewenstein Mozes Process for preparing improved compounds having narcotic effect
US936254A (en) * 1908-01-06 1909-10-05 Belden Mfg Co Attachment for telephones.
DE377588C (de) * 1922-08-29 1923-06-22 O Hinsberg Dr Verfahren zur Darstellung einer salzartigen Verbindung des Codeins
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US3895063A (en) * 1965-04-08 1975-07-15 Ciba Geigy Corp Substituted Anilino Benzyl Alcohols
FR2051482B1 (no) * 1969-04-04 1973-06-08 Rabot Ets David
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
FR2257606B1 (no) * 1974-01-10 1978-02-24 Sumitomo Chemical Co
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
FI913949A (fi) 1992-02-24
PT98731B (pt) 1999-01-29
US5190947A (en) 1993-03-02
NO179175B (no) 1996-05-13
EP0472501B1 (de) 1996-05-08
NO179175C (no) 1996-08-21
KR920004391A (ko) 1992-03-27
HU912768D0 (en) 1992-01-28
CA2049649A1 (en) 1992-02-24
EP0472501A3 (en) 1993-02-24
FI96421B (fi) 1996-03-15
DK0472501T3 (da) 1996-05-28
PT98731A (pt) 1992-07-31
AU652951B2 (en) 1994-09-15
GR3019872T3 (en) 1996-08-31
IL99213A (en) 1995-07-31
DE59107784D1 (de) 1996-06-13
TW225536B (no) 1994-06-21
EP0472501A2 (de) 1992-02-26
ES2086515T3 (es) 1996-07-01
JPH04257587A (ja) 1992-09-11
NO913295D0 (no) 1991-08-22
ATE137753T1 (de) 1996-05-15
FI913949A0 (fi) 1991-08-21
AU8268591A (en) 1992-02-27
IL99213A0 (en) 1992-07-15
HU209308B (en) 1994-04-28
IE912973A1 (en) 1992-02-26
NZ239495A (en) 1997-05-26
ZA916642B (en) 1992-04-29
FI96421C (fi) 1996-06-25
HUT60501A (en) 1992-09-28
IE72479B1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
NO913295L (no) Kodeinsalt av en substituert karboksylsyre, fremgangsmaatefor fremstilling derav og anvendelse derav.
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
IT1235048B (it) Derivato di 4h-benzopiran-4-one o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo
SE8700499D0 (sv) Novel pharmacologically active compounds
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
AU1300383A (en) Amides useful in the treatment of diabetes
ATE6640T1 (de) N-benzoyl-alpha-anilinoalkylcarboxylsaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
SE8404308D0 (sv) Polyprenylkarboxylsyraamider, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande dessa foreningar
RU98103388A (ru) (r)-5-бром-n-(1-этил-4-метилгексагидро-1н-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения и фармацевтическая композиция, содержащая указанное соединение
ATE149T1 (de) 2-(n-(2'-chlor-4'-methylthienyl-3')-n-(cyclopropyl- methyl)-amino)-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung.
DE3068456D1 (en) 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation
IE820118L (en) Anthranilic acid.
HU9200363D0 (en) Process for the production of novel salts of 2-(2,6-dichloranilyno)-phenyl-acetic acid and medical preparations containing such active agents
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
RU99108789A (ru) Ингибитор субэпителиального помутнения роговицы
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)